Patents
Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673)
12/2005
12/14/2005CN1708514A Hydroxyalkyl starch derivatives
12/14/2005CN1706865A Branched polyglycol-amino acid oligopeptide and its active derivative and medicinal composition
12/08/2005WO2005116255A2 Aptamer-toxin molecules and method for using same
12/08/2005WO2005116085A1 Protein-cyclodextrin derivatives
12/08/2005WO2005116081A2 Stable protein storage and stable nucleic acid storage in recoverable form
12/08/2005US20050272058 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/08/2005CA2567720A1 Stable protein storage and stable nucleic acid storage in recoverable form
12/07/2005EP1601697A1 Antibody purification by Protein A and ion exchange chromatography
12/07/2005CN1230682C Method for detecting and quantizing destination molecule and apparatus for detection and reading
12/06/2005US6972326 Labeling of immobilized proteins using dipyrrometheneboron difluoride dyes
12/01/2005WO2005005614A3 Combined b-cell and t-cell epitopes on vlp for improved vaccines
12/01/2005US20050266524 Beta integrin gene and protein
12/01/2005US20050266461 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/2005
11/30/2005EP1599227A2 Methods of immunomodulation in animals
11/30/2005EP1003853B1 Methods for protein screening
11/30/2005CN1229388C N-terminal modified protein compositions and methods therefor
11/30/2005CN1229385C Composition for stimulating megacaryocyte growth and differentiation and process thereof
11/29/2005CA2146964C Particles having gelatin-aminodextran coatings of and processes for making same
11/24/2005US20050261473 Carboxy protection strategies for acidic c-terminal amino acids in chemical ligation of oligopeptides
11/24/2005US20050260674 Specific polypeptides, useful as nematocides
11/24/2005US20050260673 nematode-specific gene products that can serve as targets for inhibitory peptides and proteins (e.g., antibodies) and antiparasitic chemicals
11/24/2005US20050260632 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/24/2005US20050260622 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/24/2005US20050260197 Receptor for Oncostatin M
11/24/2005DE19742156B4 Funktionelle dünne Filme und ein Verfahren zu deren Herstellung Functional thin films and a process for their preparation
11/23/2005EP1597350A2 Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection
11/22/2005US6967240 proteinaceous compound or functionally active derivative thereof having a binding site for a group of toxins derived from various cyanobacteria, to a method for its production, diagnostic kits, and affinty matrix for use in immunoaffinity column
11/17/2005WO2005107491A2 Multi-lectin affinity chromatography and uses thereof
11/17/2005US20050256049 Chimeric toxins for targeted therapy
11/16/2005EP1595890A2 Synthetic peptide inhibitors of HIV transmission
11/16/2005EP1594533A2 Antibody vaccine conjugates and uses therefor
11/16/2005EP1594444A2 Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections
11/15/2005US6964761 Administering and depositing interferon in the lungs; for patients are unresponsive to treatment with corticosteroid, cyclophosphamide, and azathioprine; therapeutic dosage pluse immunosuppressant or antiinflammatory agent; drug delivery
11/10/2005WO2005105151A1 Pegylated thymosin 1 derivatives
11/10/2005US20050250136 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/10/2005US20050249737 Dendritic cell potentiation
11/10/2005CA2564131A1 Novel therapeutic targets in cancer
11/10/2005CA2563809A1 Water-soluble, uv-absorbing and/or fluorescent components with very high isoelectric points
11/09/2005EP0760857B1 Receptor for oncostatin m
11/03/2005WO2005103259A1 Sars-cov nucleocapsid protein epitopes and uses thereof
11/03/2005WO2005055957A3 Influenza immunogen and vaccine
11/03/2005WO2005019831B1 Methods for reducing complexity of a sample using small epitope antibodies
11/03/2005WO2005009396A3 Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections
11/03/2005US20050245730 Wound healing agents; anticancer agents; cardiovascular disorders; immunostimulants
11/03/2005US20050245727 Consisting of a four helix bundle formed of two dimerized helix-loop-helix motifs; for use in biosensing applications
11/03/2005US20050244852 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/03/2005US20050244372 Interleukin-3 (IL-3) multiple mutation polypeptides
11/03/2005US20050242039 Deposition of dissolved analyte to hydrophobic surfaces by desolvation of organic solvents
11/02/2005EP1590434A2 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
11/02/2005EP1589994A2 Composition and method for preventing or treating a virus infection
11/02/2005CN1690079A Polyethylene glycol-modified thymus peptide 1 derivatives
11/01/2005US6960457 Reversible immobilization of arginine-tagged moieties on a silicate surface
10/2005
10/27/2005WO2005040338A3 Constrained alkaloid immunogens and antibodies and uses thereof
10/27/2005US20050238723 Method of producing hydroxyalkyl starch derivatives
10/27/2005CA2786794A1 Prodrug linker
10/26/2005EP1587840A2 Method to form a protein microarray system
10/26/2005EP1587839A2 Light induced immobilisation
10/26/2005EP1587476A2 Novel compositions and methods in cancer
10/25/2005US6958148 microparticle comprising active agent and polymer having transglutaminase substrate reactive groups, wherein reactive groups are surface available, and polymer comprises amino acids having at least three contiguous linked glutamines; drug delivery
10/20/2005WO2005096706A2 Antibody to 5'-deoxy-5'-methylthioadenosine and uses thereof
10/20/2005WO2005004798A3 Methods for treating lentivirus infections
10/20/2005US20050234230 formed via reductive amination with O-[2-(2-aminooxy-ethoxy)-ethyl]-hydroxyl amine; conjugated to erythropoietin
10/20/2005US20050233343 Composition of matter comprising library of analytes hybridized to nucleic acid array for generating complex formation and signaling domains
10/19/2005EP1585960A2 Mucin immobilized chromatography
10/19/2005EP1585546A2 Kim-1 antagonists and use to modulate immune system
10/19/2005CN1685064A Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
10/19/2005CN1683414A Process for preparing stereo arrested amine nitrogen oxygen free redical with hydrotalcite analog as catalyst
10/18/2005US6956051 amphiphilic drug-oligomer conjugates comprising a therapeutic compound conjugated to an oligomer, wherein the oligomer comprises a lipophilic moiety coupled to a hydrophilic moiety; therapeutic agents coupled to amphiphilic oligomers
10/18/2005US6955915 Solid phase synthesis; photolithography
10/18/2005CA2184386C Interference eliminating agent for application in immunoassays
10/13/2005WO2005095962A1 Method for immobilizing polypeptides and solid supports having polypeptides immobilized thereon
10/13/2005US20050227924 Peyer's patch and/or M-cell targeting ligands
10/13/2005US20050226866 Bone morphogenic protein specific immunoglobulin for treatment of bone diseases; immunotherapy
10/12/2005EP1583824A1 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection
10/12/2005EP1583816A2 Protein arrays
10/12/2005EP1583557A2 Vaccine compositions and methods
10/12/2005CN1681846A Process for producing hydroxyalkyl starch derivatives
10/12/2005CN1681844A Hasylated polypeptides, especially hasylated erythropoietin
10/12/2005CN1681527A Therapies for renal failure using interferon-beta
10/12/2005CN1680458A Activated macrogol of modified protein and preparation thereof
10/12/2005CN1680449A Recombinant erythropoietin with intracorporeal physical activity and modified by macrogol
10/12/2005CN1680448A Macrogol-interferon, preparation and use thereof
10/12/2005CN1680407A Preparation of triazoline artificial semi-antigen, antigen and antibody
10/12/2005CN1680406A Triazoline artificial semi-antigen, antigen, specific antibody and use thereof
10/12/2005CN1680405A Chlorpyrifos artificial semiantigen, antigen, antibody and use, synthesis of semiantigen
10/11/2005US6953840 Methods of using non-human animal Apolipoprotein A-I protein
10/11/2005US6953836 PRO844 polypeptides
10/06/2005WO2005093417A1 Assays for amphetamine and methamphetamine using stereospecific reagents
10/06/2005WO2004084812A3 Tamandarin analogs and fragments thereof and methods of making and using
10/06/2005US20050220763 Method of treating idiopathic pulmonary fibrosis with aerosolized IFN-gamma
10/06/2005DE102005011926A1 Immobilizing proteins on polymer substrates that are used in catalytic chemical reactions, comprises cross linking the proteins in the presence of bifunctional olefinic compounds and fixed durably at the substrate by UV light irradiation
10/05/2005EP1581645A2 Method for using division arrested cells in screening assays
10/05/2005EP1581550A2 Pharmaceutical compositions preparation of peptides, secreted by the snake venom glands, particulary of bothrops jararaca, vasopeptidases inhibitors, evasins, their analogues, derivatives and products associated, thereof. for development of aplications and use in chronic-degenerative diseases
10/05/2005CN1678625A Humanized anti-lymphotoyin beta receptor antibodies
10/04/2005US6951920 PRO1340 polypeptides
10/04/2005US6951745 Polyhydroxyalkanoate-containing structure and manufacturing method thereof
10/04/2005CA2094397C Homobifunctional agents for coupling enzymes and the like to antibodies and the like
09/2005
09/29/2005WO2005068087A3 Method for coating an object with hydrophobin at low temperatures
09/29/2005WO2005051976A3 Protein and peptide ligation processes and one-step purification processes
09/29/2005WO2005014792A3 Preservation of biomaterials with transported preservation agents
1 ... 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 ... 107